18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 5, 2007, Pages 1630-1634

  Jung, Min Kim ^a   Ryu, Jin Sook ^a   Tae, Yong Kim ^a   Won, Bae Kim ^a   Gui, Young Kwon ^a   Gong, Gyungyub ^a   Dae, Hyuk Moon ^a   Seong, Chul Kim ^a   Suck, Joon Hong ^a   Young, Kee Shong ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CYTODIAGNOSIS; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; FOLLICULAR CARCINOMA; HUMAN; HYPERMETABOLISM; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CANCER; THYROID FOLLICULAR NEOPLASM; THYROID GLAND; THYROID NODULE; THYROID TUMOR; ADENOMA; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; SCINTISCANNING;

ADENOMA; ADENOMA, OXYPHILIC; ADULT; AGED; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYROID NODULE;

EID: 34249858278     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2311     Document Type: Article

References (22)

1. Lowhagen T, Sprenger E 1974 Cytologic presentation of thyroid tumors in aspiration biopsy smear. A review of 60 cases. Acta Cytol 18:192-197
2. Juweid ME, Cheson BD 2006 Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354:496-507
3. Line BR, White CS 2004 Positron emission tomography scanning for the diagnosis and management of lung cancer. Curr Treat Options Oncol 5:63-73
4. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK 2001 Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914-924
5. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF 2001 Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130:941-946
6. Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I, Kumnig G, Lind P 2003 Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 133:294-299
7. Carling T, Udelsman R 2005 Follicular neoplasms of the thyroid: what to recommend. Thyroid 15:583-587
8. Chen H, Nicol TL, Udelsman R 1995 Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 222:101-106
9. Miller B, Burkey S, Lindberg G, Snyder III WH, Nwariaku FE 2004 Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 188:459-462
10. Kim ES, Nam-Goong IS, Gong G, Hong SJ, Kim WB, Shong YK 2003 Post-operative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called 'follicular neoplasm.' Korean J Intern Med 18:94-97
11. Bloom AD, Adler LP, Shuck JM 1993 Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 114:728-734
12. Sasaki M, Ichiya Y, Kuwabara Y, Akashi Y, Yoshida T, Fukumura T, Masuda K 1997 An evaluation of FDG-PET in the detection and differentiation of thyroid tumours. Nucl Med Commun 18:957-963
13. Uematsu H, Sadato N, Ohtsubo T, Tsuchida T, Nakamura S, Sugimoto K, Waki A, Takahashi N, Yonekura Y, Tsuda G, Saito H, Hayashi N, Yamamoto K, Ishii Y 1998 Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 39:453-459
14. Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S 2005 Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery 138:1166-1174
15. de Geus-Oei LF, Pieters GF, Bonenkamp JJ, Mudde AH, Bleeker-Rovers CP, Corstens FH, Oyen WJ 2006 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med 47:770-775
16. Joensuu H, Ahonen A, Klemi PJ 1988 18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy. Eur J Nucl Med 13:502-506
17. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK 2005 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 115:1074-1078
18. Rohren EM 2004 Intense FDG uptake in a benign Hurthle cell adenoma. Clin Nucl Med 29:664-666
19. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, Horiuchi M 1998 Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 207:775-778
20. Matsuzu K, Segade F, Matsuzu U, Carter A, Bowden DW, Perrier ND 2004 Differential expression of glucose transporters in normal and pathologic thyroid tissue. Thyroid 14:806-812
21. Haber RS, Weiser KR, Pritsker A, Reder I, Burstein DE 1997 GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 7:363-367
22. Schonberger J, Ruschoff J, Grimm D, Marienhagen J, Rummele P, Meyringer R, Kossmehl P, Hofstaedter F, Eilles C 2002 Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study. Thyroid 12:747-754